1:00pm, Monday, 17 October
Room BIG13, Ground Floor
710 Cumberland St
Associate Professor Shyamal Das
School of Pharmacy, University of Otago
‘Formulations for lung diseases’
Lung diseases such as COPD, asthma, lung infections including tuberculosis and non-cystic bronchiectasis, and COVID-19 are some of the leading causes of morbidity and death. One of the key hurdles to develop an efficient treatment for infections with a biologically active molecule is to develop an appropriate formulation and delivery. In this presentation, I will present how we develop formulations for treating lung diseases.